Bendazac L-Lysine
Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
Product Specifications
CAS Number
81919-14-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Amino Acid Derivatives
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/Bendazac_L-Lysine.html
Concentration
10mM
Purity
99.35
Solubility
H2O : 25 mg/mL (ultrasonic)
Smiles
O=C(O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3.N[C@@H](CCCCN)C(O)=O
Molecular Formula
C22H28N4O5
Molecular Weight
428.48
Precautions
H302, H315, H319, H335
References & Citations
[1]Yin XX, et al. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
Patent. US20240216332A1.|Patent. US20240216332A1.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
